Tier A: Venture CapitalVenture Capital
ARCH Venture Partners
HQ
Chicago, IL, USA
Founded
1986
AUM
Undisclosed
Portfolio
6 companies
AI × Biotech Thesis
Prolific early-stage biotech investor with deep AI platform exposure. Early backer of Illumina, Juno, Vir Biotechnology; aggressive 2022-2025 deployment into AI-native biotech including Isomorphic-adjacent plays.
Verified Investments
6 companies- Recursion Pharmaceuticals
- Insitro
- Genesis Therapeutics
- Editas Medicine
- Absci
- Generate:Biomedicines (co-investor)
· Dot indicates company has a profile page on biotech.today
Active Partners
2 on record- Bob NelsenCo-Founder & Managing Director
- Steve GillisManaging Director
Frequent Co-Investors
- Catalio Capital Management2 shared · Absci, Recursion Pharmaceuticals
- Lux Capital2 shared · Recursion Pharmaceuticals, Genesis Therapeutics
- OrbiMed2 shared · Absci, Recursion Pharmaceuticals
- RA Capital Management2 shared · Recursion Pharmaceuticals, Absci
- Section 322 shared · Absci, Generate:Biomedicines (co-investor)